BioTelemetry, Inc. (NASDAQ:BEAT) had a successful 3Q in which both earnings and revenue surpassed the estimates. The company posted adjusted earnings of $0.06 per share, which was ahead of the estimate of $0.01 for the quarter. On the revenue front, the $224 million maker of medical devices generated $43.1 million, which topped the estimate of $42.2 million.
Analyst have identified a trend in BEAT. Get the free report!
Shares of BioTelemetry, Inc. (NASDAQ:BEAT) have edged up nearly 6% since the beginning of the year.
BioTelemetry, Inc. (NASDAQ:BEAT) carries consensus “Hold” rating and average target price of $11.60.
Pacific Ethanol Inc (NASDAQ:PEIX) posted 3Q financial results that showed significant improvements from last year’s same period. The company cited that the quarter was helped by improvement in the operation efficiencies and attractive market fundamentals. However, experts have cited that all may not well for the ethanol suppliers because of the shaky price environment. The demand for the product is also expected almost to stagnate.
Will PEIX continue on its latest trend? Get the free report!
Pacific Ethanol Inc (NASDAQ:PEIX) posted adjusted $0.33 per share in the latest quarter, which was better than a loss of $0.26 per share in the like quarter last year. Revenue was up to $275.6 million from $233.88 million last year. Analysts on the average were looking for earnings of $0.21 per share on revenue of $261.55 million.
The latest quarter signaled strong rebound in the stock following some years of performance slump as the market conditions became unbearable. Pacific Ethanol Inc (NASDAQ:PEIX) was forced to shut down certain of its plants because of the market challenges.
Solazyme Inc (NASDAQ:SZYM) altered the performance landscape of this year’s troubled first half to report a profit in 3Q. The regional airline operated posted losses in the first half of the year is it battled a harsh winter condition and high costs and expenses associated with crew training and more. However, lower maintenance costs and further austerity measures helped 3Q to bring the company to profitability in the quarter.
How are market trends affecting SZYM? Find out here!
Solazyme Inc (NASDAQ:SZYM) earned a net income of $41.3 million in the latest quarter, which was up more than 56% from the same period last year. Revenue for the latest quarter was $834.6 million, down nearly 2% from last year.
